Cabio Biotech (Wuhan) Co., Ltd. (SHA:688089)
China flag China · Delayed Price · Currency is CNY
25.24
-0.71 (-2.74%)
May 9, 2025, 2:45 PM CST

Cabio Biotech (Wuhan) Company Description

Cabio Biotech (Wuhan) Co., Ltd. develops, produces, and markets arachidonic and docosahexaenoic acids, and beta-carotene for domestic and foreign infant formula, and healthy food manufacturers.

Its products are used in infant formula food, health food, dietary supplements, and other fields for special medical purposes, pet nutrition food, economic animal feed, personal care and cosmetics, and other fields.

The company was founded in 1999 and is based in Wuhan, the People’s Republic of China.

Cabio Biotech (Wuhan) Co., Ltd.
Country China
Founded 1999
Industry Biotechnology
Sector Healthcare
Employees 565
CEO Dewei Yi

Contact Details

Address:
No. 999 high-tech Avenue
Wuhan, 430073
China
Phone 86 27 6784 5351
Website cabio.cn

Stock Details

Ticker Symbol 688089
Exchange Shanghai Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
ISIN Number CNE100005X31
SIC Code 2890

Key Executives

Name Position
Dewei Yi Chairman and GM
Huabiao Wang Financial Director and Director
Huarong Yi Deputy GM and Secretary of the Board of Directors
Anfeng Geng Deputy General Manager
Zhiming Wang Deputy General Manager
Xiangyu Li Deputy General Manager
Tao Ma Deputy General Manager
Hao Xiong Accounting Supervisor